Decipher Labs (BOM:524752) EBIT per Share : ₹-0.97 (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Decipher Labs EBIT per Share?

Decipher Labs's EBIT per Share for the three months ended in Mar. 2024 was ₹1.37. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-0.97.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Decipher Labs's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Decipher Labs was 174.10% per year. The lowest was -10.90% per year. And the median was 77.50% per year.

BOM:524752's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Decipher Labs's EBIT for the three months ended in Mar. 2024 was ₹13.8 Mil.

Decipher Labs EBIT per Share Historical Data

The historical data trend for Decipher Labs's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decipher Labs EBIT per Share Chart

Decipher Labs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

2.17

3.24

12.71

-3.70

-0.98

Decipher Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-3.72	-0.24	-2.11	0.01	1.37

Decipher Labs EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Decipher Labs's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-9.935	/	10.094
=	-0.98

Decipher Labs's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	13.751	/	10.055
=	1.37

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.97

Decipher Labs (BOM:524752) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Decipher Labs EBIT per Share Related Terms

Thank you for viewing the detailed overview of Decipher Labs's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Decipher Labs (BOM:524752) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Decipher Labs Ltd (BOM:524752) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

Road No. 2, 4th Floor, Plot No. 94, Sagar Society, Banjara Hills, Hyderabad, TG, IND, 500034

Website

http://www.decipherlabs.in

Decipher Labs Ltd, formerly Combat Drugs Ltd is an India-based company engaged in the trading and manufacturing of Pharmaceutical drugs. It also undertakes contract manufacturing services business. The group generates revenue from the sale of its pharmaceutical products.

Decipher Labs (BOM:524752) Headlines

No Headlines